Hypoxic-Ischaemic Encephalopathy Recruiting Phase 3 Trials for Erythropoietin (DB00016)

Also known as: Encephalopathy, Hypoxic-Ischemic / Hypoxic-Ischemic Encephalopathy / Hypoxic ischemic encephalopathy [HIE], unspecified / Hypoxic ischemic brain injury

IndicationStatusPhase
DBCOND0080116 (Hypoxic-Ischaemic Encephalopathy)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03079167PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in NewbornsTreatment